Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex A Aimetti

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Epilepsy Research|March 13, 2024
Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112]Joseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
ACS Nano|May 4, 2013
Injectable nano-network for glucose-mediated insulin deliveryZhen Gu, Alex A Aimetti, Qun Wang, et al.
Epilepsy Research|March 4, 2023
Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsyJoseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
Neurosurgery|September 1, 2018
Method and Apparatus for the Automated Delivery of Continuous Neural Stem Cell Trails Into the Spinal Cord of Small and Large AnimalsArtem B Kutikov, Simon W Moore, Richard T Layer, et al.
Biomaterials|September 29, 2018
Internal decompression of the acutely contused spinal cord: Differential effects of irrigation only versus biodegradable scaffold implantationJames D Guest, Simon W Moore, Alex A Aimetti, et al.
Spine|December 3, 2015
Sustained Local Release of Methylprednisolone From a Thiol-Acrylate Poly(Ethylene Glycol) Hydrogel for Treating Chronic Compressive Radicular PainJonathan R Slotkin, Jennifer K Ness, Kristin M Snyder, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Epilepsy Research|March 13, 2024
Corrigendum to "Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy" [Epilepsy Res. (2023) 191 107112]Joseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
ACS Nano|May 4, 2013
Injectable nano-network for glucose-mediated insulin deliveryZhen Gu, Alex A Aimetti, Qun Wang, et al.
Epilepsy Research|March 4, 2023
Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsyJoseph Sullivan, Boudewijn Gunning, Muhammad Zafar, et al.
Neurosurgery|September 1, 2018
Method and Apparatus for the Automated Delivery of Continuous Neural Stem Cell Trails Into the Spinal Cord of Small and Large AnimalsArtem B Kutikov, Simon W Moore, Richard T Layer, et al.
Biomaterials|September 29, 2018
Internal decompression of the acutely contused spinal cord: Differential effects of irrigation only versus biodegradable scaffold implantationJames D Guest, Simon W Moore, Alex A Aimetti, et al.
Spine|December 3, 2015
Sustained Local Release of Methylprednisolone From a Thiol-Acrylate Poly(Ethylene Glycol) Hydrogel for Treating Chronic Compressive Radicular PainJonathan R Slotkin, Jennifer K Ness, Kristin M Snyder, et al.
Epilepsia|November 11, 2023
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-upHeather E Olson, Sam Amin, Nadia Bahi-Buisson, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trialElia M Pestana Knight, Sam Amin, Nadia Bahi-Buisson, et al.
Pageof 2